About

Publications While At HealthPartners

selected publications

Journal Article

A novel immune modulator for patients with necrotizing soft tissue infections (NSTI): results of a multicenter, phase 3 randomized controlled trial of reltecimod (AB 103). 

Annals of Surgery. 2020

Contact

full name

ACCUTE Study Investigator

Quick Info

 

Collaboration

Co-author network

Map of science